These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11034930)

  • 1. Matrix matters.
    Libby P; Lee RT
    Circulation; 2000 Oct; 102(16):1874-6. PubMed ID: 11034930
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibroblast contributions to ischemic cardiac remodeling.
    Burke RM; Burgos Villar KN; Small EM
    Cell Signal; 2021 Jan; 77():109824. PubMed ID: 33144186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruptions and detours in the myocardial matrix highway and heart failure.
    Deschamps AM; Spinale FG
    Curr Heart Fail Rep; 2005 Mar; 2(1):10-7. PubMed ID: 16036046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling.
    Li YY; McTiernan CF; Feldman AM
    Cardiovasc Res; 2000 May; 46(2):214-24. PubMed ID: 10773225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Myocardial Extracellular Matrix Dynamic Changes in Myocardial Infarction and Postinfarct Remodeling.
    Ushakov A; Ivanchenko V; Gagarina A
    Curr Cardiol Rev; 2020; 16(1):11-24. PubMed ID: 31072294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure.
    Schram K; Sweeney G
    Trends Cardiovasc Med; 2008 Aug; 18(6):199-205. PubMed ID: 19185809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target.
    Spinale FG; Coker ML; Bond BR; Zellner JL
    Cardiovasc Res; 2000 May; 46(2):225-38. PubMed ID: 10773226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling.
    Lindsey ML; Iyer RP; Jung M; DeLeon-Pennell KY; Ma Y
    J Mol Cell Cardiol; 2016 Feb; 91():134-40. PubMed ID: 26721597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanisms of extracellular matrix remodeling in dilated cardiomyopathy].
    Pauschinger M; Chandrasekharan K; Li J; Schwimmbeck PL; Noutsias M; Schultheiss HP
    Herz; 2002 Nov; 27(7):677-82. PubMed ID: 12439639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioactive peptide signaling within the myocardial interstitium and the matrix metalloproteinases.
    Spinale FG
    Circ Res; 2002 Dec; 91(12):1082-4. PubMed ID: 12480806
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibroblasts and the extracellular matrix in right ventricular disease.
    Frangogiannis NG
    Cardiovasc Res; 2017 Oct; 113(12):1453-1464. PubMed ID: 28957531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of PI3Kγ enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress.
    Guo D; Kassiri Z; Basu R; Chow FL; Kandalam V; Damilano F; Liang W; Izumo S; Hirsch E; Penninger JM; Backx PH; Oudit GY
    Circ Res; 2010 Nov; 107(10):1275-89. PubMed ID: 20847309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
    Yang YJ; Zhang X; Zhu WL; Huang Y
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular matrix remodeling in hypertensive heart disease.
    Shirwany A; Weber KT
    J Am Coll Cardiol; 2006 Jul; 48(1):97-8. PubMed ID: 16814654
    [No Abstract]   [Full Text] [Related]  

  • 15. Alteration of matrix metalloproteinases in selective left ventricular adriamycin-induced cardiomyopathy in the pig.
    Goetzenich A; Hatam N; Zernecke A; Weber C; Czarnotta T; Autschbach R; Christiansen S
    J Heart Lung Transplant; 2009 Oct; 28(10):1087-93. PubMed ID: 19782292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial structure and matrix metalloproteinases.
    Aggeli C; Pietri P; Felekos I; Rautopoulos L; Toutouzas K; Tsiamis E; Stefanadis C
    Curr Top Med Chem; 2012; 12(10):1113-31. PubMed ID: 22519443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular remodeling: one small step for the extracellular matrix will translate to a giant leap for the myocardium.
    Yabluchanskiy A; Chilton RJ; Lindsey ML
    Congest Heart Fail; 2013; 19(4):E5-8. PubMed ID: 23350683
    [No Abstract]   [Full Text] [Related]  

  • 18. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice.
    Shiomi T; Tsutsui H; Matsusaka H; Murakami K; Hayashidani S; Ikeuchi M; Wen J; Kubota T; Utsumi H; Takeshita A
    Circulation; 2004 Feb; 109(4):544-9. PubMed ID: 14744974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix modulation and heart failure: new concepts question old beliefs.
    Deschamps AM; Spinale FG
    Curr Opin Cardiol; 2005 May; 20(3):211-6. PubMed ID: 15861009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases: pathways of induction by bioactive molecules.
    Tsuruda T; Costello-Boerrigter LC; Burnett JC
    Heart Fail Rev; 2004 Jan; 9(1):53-61. PubMed ID: 14739768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.